SlideShare a Scribd company logo
PENETRATION ENHANCER FOR TDDS
Presented by-
Shubham N. Gharat
M.pharm
Department of Pharmaceutics
Guided by-
Prof. A. D. Savkare
Department of Pharmaceutics
M.V.P’s College of Pharmacy Nashik-2
1
Introduction:
• Most drug don’t have ability to penetrate stratum corneum so skin penetration
enhancer used.
• The success of penetration enhancer depends upon on the ability of the drug to
penetrate through skin in sufficient quantities to achieve the desire therapeutic
effect.
• These are the chemical which interact with skin constituents and promote the drug
flux.
2
Skin
• The outermost layer of skin is
SC which act as a barrier.
• Bilayer lipids and surrounding
corneocytes produce Brick and
Mortar model.
Layers:
• Stratum Corneum
• Epidermis
• Dermis
• Subcutaneous tissue
3
Penetration Enhancer:
• Penetration enhancer is a substance which used to promote the drug
transport across the skin barrier.
• It temporarily diminishing the barrier of the skin.
• It also known as accelerants and sorption promoters can enhance drug
flux.
4
Routes of penetration enhancer:
5
1. through the sweat ducts 2. directly across the stratum corneum 3. via the hair follicles
Factor Affecting Skin Penetration:
• pH
• Temperature
• Molecular Weight
• Partition Coefficient
• Age
• Gender
• Body site
• Skin Exposure
• Blood flow
• Skin Condition
6
Ideal Characteristics:
• It should reduce the barrier resistance of the stratum corneum without damaging
the cells.
• It should be non-toxic , non-irritating and non-allergic.
• It should work rapidly , the activity and duration of effect should be both
predictable and reproducible.
• It should cosmetically acceptable with an appropriate skin feel.
• The penetration enhancer should work unidirectionally.
• When penetration enhancer remove from skin , barrier properties should return
both rapidly and fully to normal.
• The substance should be an excellent solvent for drugs.
7
Types Of Penetration Enhancer:
Drug Vehicle Based:
• Drug Selection
• Vesicles and Particles
• Prodrug and ion pairs
• Chemical potential of Drug
• Eutectic System
• Complexes
8
Chemical Penetration Enhancer:
Solvents:
• Alcohols
• Water
• Sulfoxides
• Pyrrolidones
• Azone
• Miscellaneous solvent
Surfactants:
• Anionic surfactants
• Cationic surfactants
• Non-ionic surfactants
• Fatty acid and alcoholes
9
Miscellaneous Chemicals:
• Urea
• N, N-diethyl-m-toluamide
• Calcium thioglycolate
• Anticholinergic agents
• Miscellaneous
10
Physical Methods:
• Iontophoresis
• Ultrasound
• Magnetophoresis
• Electroporation
• Radio frequency
• Thermophoresis
• Microneedle array
• Skin stretching
• Skin abrasion
11
Mechanism Of Penetration Enhancer:
Lipid Disruption (Disruption of highly ordered SC)
Protein Modification (Interaction with intercellular protein)
Partitioning Promotion
12
Contd.
13
Chemical penetration enhancer: Solvents
Alcohol :
Ethanol and Methanol
Mode of Action:
• Removal of lipids from stratum corneum results in loss of partitioning
influence on permeability.
• And large increase in the permeation rate of both polar and nonpolar
permeates.
Ex. Estradiol and Nitroglycerine
14
Water
Hydration of the stratum corneum will decrease in barrier function.
Hydration increase transdermal delivery of both hydrophilic and hydrophobic drug.
Mode of action:
• Water act as solvent and alter solubility of permeants and so its partitioning.
• Also on hydration corneocytes may swell and open the structure of the stratum
corneum leading to increase in permeation.
15
Sulfoxide
Dimethyl sulfoxide, Dimethyl acetamide, Dimethyl formamide
Mode of action :
• Extraction of stratum corneum lipids and lipoproteins.
• Interaction with the head group of bilayer lipids to distort the packing geometry.
• Delamination of horny layer(SC)
Ex. Griseofulvin, lidocaine
16
Pyrrolidones
Sodium pyrrolidone carboxylate, 2-pyrrolidone and N-methyl-2-pyrrolidone
Mode of action :
• Act by altering solvent nature of membrane and Pyrrolidones used to generate
reservoirs with in skin membrane.
• Such reservoir effect offers potential for sustain release of permeant.
Ex. Captopril , Caffeine , Ibuprofen
17
Amide
Azone
• Effective enhancer for both hydrophilic and hydrophobic drug.
• Increase in effectiveness by adding cosolvent ex. PG
Mode of action:
• Mechanisms yet unresolved
• But alterations in SC detected by DSC and FTIR.
• Azone probably act by disrupting horney layer lipid structure
Ex. Antibiotic: Clindamycin, erythromycin , Steroids: amcinonide, Indomethacin
and Naloxone.
18
Surfactants
Anionic surfactants:
It can penetrate and destroy the integrity of SC within hours.
Ex. Sodium Lauryl Sulphate
MOA:
• It induced swelling of SC and viable epidermis.
• The hydrophobic interaction of the alkyl chains with the substrate leaves the negative
end group of the surfactant exposed, creating additional anionic sites in the
membrane.
• This results in development of repulsive forces which separate the protein matrix,
uncoil the filaments and expose more water-binding sites.
Ex. Naproxen, Chloramphenicol
19
Cationic surfactant:
Alkyl amines
MOA:
• At the outer skin surface the amine has the capacity to form an ion pair with the
drug.
• The ion pair have high solubility in skin than parent anion which diffuses through
own concentration gradient to the inner sc .
• Then amine deprotonates and liberate the anion after that the amine free to travel
back to the skin surface.
• Only small amount of amine required for this carrier mechanism.
Ex. Na and K ion, Naloxone
20
Non-ionic surfactants:
Span 80, Tween 80
MOA:
• Increase fluidity in lipid phase of stratum corneum region which reduces
diffusional resistance.
Ex. Hydrocortisone, Lidocaine
Fatty Acid and Alcohols
MOA:
• Act as solvent and alter solubility properties of tissue leads to improve
partitioning.
• Evaporation of solvent increase drug concentration.
Ex. Acyclovir, Mannitol
21
Miscellaneous Chemicals:
Urea
MOA:
• It increase the hydration of SC and it also have keratolytic effects .
Ex. Hydrocortisone
N, N-Dimethyl-m-Toluamide
MOA:
• In this MOA is needs more study and usefulness on human skin is sparse.
Ex. Mosquito repellent
22
Calcium Thioglycolate
MOA:
• It probably involve the reduction of cystine links leading to disruption of a keratin
matrix.
Ex. Theophylline
Anticholinergic Agents
MOA:
• These agent have antisecretory effect but insufficient to cause systemic effect.
• Because API hindered by outflow of perspiration and formation of aqueous layer
on skin.
23
Conclusion:
• Chemical penetration enhancer are not only specific toward stratum corneum ,
they also penetrate into deeper layers of the skin to viable epidermal cells and
induce skin irritation responses.
• Penetration enhancer increase the permeation of drug but also the other
formulation excipients.
• This may lead to serious toxicological effect i.e irritation.
• Irritation produced by occlusive nature leading to accumulation of sweat and
increase in subpatch microbial growth.
• Enhancer should evaluate for irritancy under condition of long term occlusion.
24
References:
• Pathan IB, Setty CM. Chemical Penetration Enhancers for Transdermal Drug
Delivery. Trop J Res 2009;8(2):173-8.
• Singla V, Saini S, Sing G, Rana AC, Joshi B. Penetration Enhancers: A Novel
Strategy for Enhancing Transdermal Drug Delivery. IRJP 2011;2(12):32-6.
• Walters KA. Penetration Enhancer and Their Use in Transdermal Therapeutic
Systems. In: Hadgraft J, Guy RH, editor. Transdermal Drug Delivery
Development Issues and Research Initiatives, Vol-35, 1st ed. New York: Marcel
Dekker, Inc: p. 197-232.
• Mathur, V., Satrawala, Y. and Rajput, M.S., 2014. Physical and chemical
penetration enhancers in transdermal drug delivery system. Asian Journal of
Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 4(3).
25
26

More Related Content

What's hot

Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Suraj Choudhary
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
rasikawalunj
 
Drug product perfomance in vitro
Drug product perfomance in vitroDrug product perfomance in vitro
Drug product perfomance in vitro
S.N.A.Institute of Pharmacy- Haidergarh,Barabanki
 
Evaluation of protein & peptide dds
Evaluation of protein & peptide ddsEvaluation of protein & peptide dds
Evaluation of protein & peptide dds
Māľāý Păųļ
 
Compression and Compaction
Compression and CompactionCompression and Compaction
Compression and Compaction
Gaurav Patil
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
Rahul Shirode
 
Investigation of medicinal product dossier (IMPD) and investigational brochur...
Investigation of medicinal product dossier (IMPD) and investigational brochur...Investigation of medicinal product dossier (IMPD) and investigational brochur...
Investigation of medicinal product dossier (IMPD) and investigational brochur...
Arif Nadaf
 
Preformulation concept
Preformulation conceptPreformulation concept
Preformulation concept
Bashant Kumar sah
 
Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)
PRABU12345678
 
Preparation and application of Niosomes
Preparation and application of  Niosomes Preparation and application of  Niosomes
Preparation and application of Niosomes
PV. Viji
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
Kailas Mali
 
Drug excipient interaction different method
Drug excipient interaction different methodDrug excipient interaction different method
Drug excipient interaction different method
ROHIT
 
Microencapsulation
Microencapsulation Microencapsulation
Microencapsulation
Md. Shimul Bhuia
 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction
DeeptiGupta154
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
Himal Barakoti
 
Microencapsulation (2)
Microencapsulation (2)Microencapsulation (2)
Microencapsulation (2)Shivaram
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
D.R. Chandravanshi
 
Protein and peptide delivery system
Protein and peptide delivery systemProtein and peptide delivery system
Protein and peptide delivery system
Nikita Gangwani
 

What's hot (20)

Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Drug product perfomance in vitro
Drug product perfomance in vitroDrug product perfomance in vitro
Drug product perfomance in vitro
 
Evaluation of protein & peptide dds
Evaluation of protein & peptide ddsEvaluation of protein & peptide dds
Evaluation of protein & peptide dds
 
Compression and Compaction
Compression and CompactionCompression and Compaction
Compression and Compaction
 
Nasopulmonary Drug Delivery System
Nasopulmonary Drug Delivery SystemNasopulmonary Drug Delivery System
Nasopulmonary Drug Delivery System
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Investigation of medicinal product dossier (IMPD) and investigational brochur...
Investigation of medicinal product dossier (IMPD) and investigational brochur...Investigation of medicinal product dossier (IMPD) and investigational brochur...
Investigation of medicinal product dossier (IMPD) and investigational brochur...
 
Preformulation concept
Preformulation conceptPreformulation concept
Preformulation concept
 
Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)
 
Preparation and application of Niosomes
Preparation and application of  Niosomes Preparation and application of  Niosomes
Preparation and application of Niosomes
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
 
Drug excipient interaction different method
Drug excipient interaction different methodDrug excipient interaction different method
Drug excipient interaction different method
 
Microencapsulation
Microencapsulation Microencapsulation
Microencapsulation
 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
 
Microencapsulation (2)
Microencapsulation (2)Microencapsulation (2)
Microencapsulation (2)
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Protein and peptide delivery system
Protein and peptide delivery systemProtein and peptide delivery system
Protein and peptide delivery system
 

Similar to PENETRATION ENHANCER FOR TDDS

Semisolids sb 2020
Semisolids sb 2020Semisolids sb 2020
Semisolids sb 2020
Mirza Salman Baig
 
Transdermal drug delivery (1)
Transdermal drug delivery (1)Transdermal drug delivery (1)
Transdermal drug delivery (1)
LaraibTariq5
 
Lect 5a transdermal drug delivary system B 2016.ppt
Lect 5a transdermal drug delivary system B 2016.pptLect 5a transdermal drug delivary system B 2016.ppt
Lect 5a transdermal drug delivary system B 2016.ppt
AliElmehdawi2
 
Topical corticosteroids
Topical corticosteroidsTopical corticosteroids
Topical corticosteroids
Ajeet Singh
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
KniTt-In Knitts
 
Permeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery systemPermeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery system
chetanpatil2572000
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
Ravish Yadav
 
Transdermal Drug Delivery System-1 (1).pptx
 Transdermal Drug Delivery System-1 (1).pptx Transdermal Drug Delivery System-1 (1).pptx
Transdermal Drug Delivery System-1 (1).pptx
Deepali69
 
Penetration enhancers
Penetration enhancersPenetration enhancers
Penetration enhancers
Naresh Gorantla
 
Transdermal drug delivery system.pptx
Transdermal drug delivery system.pptxTransdermal drug delivery system.pptx
Transdermal drug delivery system.pptx
fidelcastro59
 
11 seminar on transdermal drug delivery system copy
11 seminar on transdermal drug delivery system   copy11 seminar on transdermal drug delivery system   copy
11 seminar on transdermal drug delivery system copy
Priyanka Galhotra
 
Transdermal drug delivery
Transdermal drug deliveryTransdermal drug delivery
Transdermal drug deliveryArya Soman
 
Transdermal Drug delivery Study
Transdermal Drug delivery Study Transdermal Drug delivery Study
Transdermal Drug delivery Study
Vaishnavi Jadhav
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
Anita Duduskar
 
Ndds 5 MUCOADHESIVE DRUG DELIVERY SYSTEM ppt
Ndds 5 MUCOADHESIVE  DRUG DELIVERY SYSTEM pptNdds 5 MUCOADHESIVE  DRUG DELIVERY SYSTEM ppt
Ndds 5 MUCOADHESIVE DRUG DELIVERY SYSTEM ppt
shashankc10
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systemsSonam Gandhi
 
transdermal srms bly
transdermal  srms  blytransdermal  srms  bly
transdermal srms bly
kaushikisingh8176
 
transdermal srms bly
transdermal  srms  blytransdermal  srms  bly
transdermal srms bly
kaushikisingh8176
 
Presentation TDDS 1.pptx
Presentation TDDS 1.pptxPresentation TDDS 1.pptx
Presentation TDDS 1.pptx
anilasajjad
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
sakshi singh
 

Similar to PENETRATION ENHANCER FOR TDDS (20)

Semisolids sb 2020
Semisolids sb 2020Semisolids sb 2020
Semisolids sb 2020
 
Transdermal drug delivery (1)
Transdermal drug delivery (1)Transdermal drug delivery (1)
Transdermal drug delivery (1)
 
Lect 5a transdermal drug delivary system B 2016.ppt
Lect 5a transdermal drug delivary system B 2016.pptLect 5a transdermal drug delivary system B 2016.ppt
Lect 5a transdermal drug delivary system B 2016.ppt
 
Topical corticosteroids
Topical corticosteroidsTopical corticosteroids
Topical corticosteroids
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
 
Permeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery systemPermeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery system
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Transdermal Drug Delivery System-1 (1).pptx
 Transdermal Drug Delivery System-1 (1).pptx Transdermal Drug Delivery System-1 (1).pptx
Transdermal Drug Delivery System-1 (1).pptx
 
Penetration enhancers
Penetration enhancersPenetration enhancers
Penetration enhancers
 
Transdermal drug delivery system.pptx
Transdermal drug delivery system.pptxTransdermal drug delivery system.pptx
Transdermal drug delivery system.pptx
 
11 seminar on transdermal drug delivery system copy
11 seminar on transdermal drug delivery system   copy11 seminar on transdermal drug delivery system   copy
11 seminar on transdermal drug delivery system copy
 
Transdermal drug delivery
Transdermal drug deliveryTransdermal drug delivery
Transdermal drug delivery
 
Transdermal Drug delivery Study
Transdermal Drug delivery Study Transdermal Drug delivery Study
Transdermal Drug delivery Study
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
 
Ndds 5 MUCOADHESIVE DRUG DELIVERY SYSTEM ppt
Ndds 5 MUCOADHESIVE  DRUG DELIVERY SYSTEM pptNdds 5 MUCOADHESIVE  DRUG DELIVERY SYSTEM ppt
Ndds 5 MUCOADHESIVE DRUG DELIVERY SYSTEM ppt
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
 
transdermal srms bly
transdermal  srms  blytransdermal  srms  bly
transdermal srms bly
 
transdermal srms bly
transdermal  srms  blytransdermal  srms  bly
transdermal srms bly
 
Presentation TDDS 1.pptx
Presentation TDDS 1.pptxPresentation TDDS 1.pptx
Presentation TDDS 1.pptx
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 

Recently uploaded

The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 

Recently uploaded (20)

The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 

PENETRATION ENHANCER FOR TDDS

  • 1. PENETRATION ENHANCER FOR TDDS Presented by- Shubham N. Gharat M.pharm Department of Pharmaceutics Guided by- Prof. A. D. Savkare Department of Pharmaceutics M.V.P’s College of Pharmacy Nashik-2 1
  • 2. Introduction: • Most drug don’t have ability to penetrate stratum corneum so skin penetration enhancer used. • The success of penetration enhancer depends upon on the ability of the drug to penetrate through skin in sufficient quantities to achieve the desire therapeutic effect. • These are the chemical which interact with skin constituents and promote the drug flux. 2
  • 3. Skin • The outermost layer of skin is SC which act as a barrier. • Bilayer lipids and surrounding corneocytes produce Brick and Mortar model. Layers: • Stratum Corneum • Epidermis • Dermis • Subcutaneous tissue 3
  • 4. Penetration Enhancer: • Penetration enhancer is a substance which used to promote the drug transport across the skin barrier. • It temporarily diminishing the barrier of the skin. • It also known as accelerants and sorption promoters can enhance drug flux. 4
  • 5. Routes of penetration enhancer: 5 1. through the sweat ducts 2. directly across the stratum corneum 3. via the hair follicles
  • 6. Factor Affecting Skin Penetration: • pH • Temperature • Molecular Weight • Partition Coefficient • Age • Gender • Body site • Skin Exposure • Blood flow • Skin Condition 6
  • 7. Ideal Characteristics: • It should reduce the barrier resistance of the stratum corneum without damaging the cells. • It should be non-toxic , non-irritating and non-allergic. • It should work rapidly , the activity and duration of effect should be both predictable and reproducible. • It should cosmetically acceptable with an appropriate skin feel. • The penetration enhancer should work unidirectionally. • When penetration enhancer remove from skin , barrier properties should return both rapidly and fully to normal. • The substance should be an excellent solvent for drugs. 7
  • 8. Types Of Penetration Enhancer: Drug Vehicle Based: • Drug Selection • Vesicles and Particles • Prodrug and ion pairs • Chemical potential of Drug • Eutectic System • Complexes 8
  • 9. Chemical Penetration Enhancer: Solvents: • Alcohols • Water • Sulfoxides • Pyrrolidones • Azone • Miscellaneous solvent Surfactants: • Anionic surfactants • Cationic surfactants • Non-ionic surfactants • Fatty acid and alcoholes 9
  • 10. Miscellaneous Chemicals: • Urea • N, N-diethyl-m-toluamide • Calcium thioglycolate • Anticholinergic agents • Miscellaneous 10
  • 11. Physical Methods: • Iontophoresis • Ultrasound • Magnetophoresis • Electroporation • Radio frequency • Thermophoresis • Microneedle array • Skin stretching • Skin abrasion 11
  • 12. Mechanism Of Penetration Enhancer: Lipid Disruption (Disruption of highly ordered SC) Protein Modification (Interaction with intercellular protein) Partitioning Promotion 12
  • 14. Chemical penetration enhancer: Solvents Alcohol : Ethanol and Methanol Mode of Action: • Removal of lipids from stratum corneum results in loss of partitioning influence on permeability. • And large increase in the permeation rate of both polar and nonpolar permeates. Ex. Estradiol and Nitroglycerine 14
  • 15. Water Hydration of the stratum corneum will decrease in barrier function. Hydration increase transdermal delivery of both hydrophilic and hydrophobic drug. Mode of action: • Water act as solvent and alter solubility of permeants and so its partitioning. • Also on hydration corneocytes may swell and open the structure of the stratum corneum leading to increase in permeation. 15
  • 16. Sulfoxide Dimethyl sulfoxide, Dimethyl acetamide, Dimethyl formamide Mode of action : • Extraction of stratum corneum lipids and lipoproteins. • Interaction with the head group of bilayer lipids to distort the packing geometry. • Delamination of horny layer(SC) Ex. Griseofulvin, lidocaine 16
  • 17. Pyrrolidones Sodium pyrrolidone carboxylate, 2-pyrrolidone and N-methyl-2-pyrrolidone Mode of action : • Act by altering solvent nature of membrane and Pyrrolidones used to generate reservoirs with in skin membrane. • Such reservoir effect offers potential for sustain release of permeant. Ex. Captopril , Caffeine , Ibuprofen 17
  • 18. Amide Azone • Effective enhancer for both hydrophilic and hydrophobic drug. • Increase in effectiveness by adding cosolvent ex. PG Mode of action: • Mechanisms yet unresolved • But alterations in SC detected by DSC and FTIR. • Azone probably act by disrupting horney layer lipid structure Ex. Antibiotic: Clindamycin, erythromycin , Steroids: amcinonide, Indomethacin and Naloxone. 18
  • 19. Surfactants Anionic surfactants: It can penetrate and destroy the integrity of SC within hours. Ex. Sodium Lauryl Sulphate MOA: • It induced swelling of SC and viable epidermis. • The hydrophobic interaction of the alkyl chains with the substrate leaves the negative end group of the surfactant exposed, creating additional anionic sites in the membrane. • This results in development of repulsive forces which separate the protein matrix, uncoil the filaments and expose more water-binding sites. Ex. Naproxen, Chloramphenicol 19
  • 20. Cationic surfactant: Alkyl amines MOA: • At the outer skin surface the amine has the capacity to form an ion pair with the drug. • The ion pair have high solubility in skin than parent anion which diffuses through own concentration gradient to the inner sc . • Then amine deprotonates and liberate the anion after that the amine free to travel back to the skin surface. • Only small amount of amine required for this carrier mechanism. Ex. Na and K ion, Naloxone 20
  • 21. Non-ionic surfactants: Span 80, Tween 80 MOA: • Increase fluidity in lipid phase of stratum corneum region which reduces diffusional resistance. Ex. Hydrocortisone, Lidocaine Fatty Acid and Alcohols MOA: • Act as solvent and alter solubility properties of tissue leads to improve partitioning. • Evaporation of solvent increase drug concentration. Ex. Acyclovir, Mannitol 21
  • 22. Miscellaneous Chemicals: Urea MOA: • It increase the hydration of SC and it also have keratolytic effects . Ex. Hydrocortisone N, N-Dimethyl-m-Toluamide MOA: • In this MOA is needs more study and usefulness on human skin is sparse. Ex. Mosquito repellent 22
  • 23. Calcium Thioglycolate MOA: • It probably involve the reduction of cystine links leading to disruption of a keratin matrix. Ex. Theophylline Anticholinergic Agents MOA: • These agent have antisecretory effect but insufficient to cause systemic effect. • Because API hindered by outflow of perspiration and formation of aqueous layer on skin. 23
  • 24. Conclusion: • Chemical penetration enhancer are not only specific toward stratum corneum , they also penetrate into deeper layers of the skin to viable epidermal cells and induce skin irritation responses. • Penetration enhancer increase the permeation of drug but also the other formulation excipients. • This may lead to serious toxicological effect i.e irritation. • Irritation produced by occlusive nature leading to accumulation of sweat and increase in subpatch microbial growth. • Enhancer should evaluate for irritancy under condition of long term occlusion. 24
  • 25. References: • Pathan IB, Setty CM. Chemical Penetration Enhancers for Transdermal Drug Delivery. Trop J Res 2009;8(2):173-8. • Singla V, Saini S, Sing G, Rana AC, Joshi B. Penetration Enhancers: A Novel Strategy for Enhancing Transdermal Drug Delivery. IRJP 2011;2(12):32-6. • Walters KA. Penetration Enhancer and Their Use in Transdermal Therapeutic Systems. In: Hadgraft J, Guy RH, editor. Transdermal Drug Delivery Development Issues and Research Initiatives, Vol-35, 1st ed. New York: Marcel Dekker, Inc: p. 197-232. • Mathur, V., Satrawala, Y. and Rajput, M.S., 2014. Physical and chemical penetration enhancers in transdermal drug delivery system. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 4(3). 25
  • 26. 26